Home>
US Stocks>
Novabay Pharmaceuticals

Novabay Pharmaceuticals share price today

(NBY)

Novabay Pharmaceuticals share price is $0.57 & ₹48.60 as on 27 Dec 2024, 2.30 'hrs' IST

$0.57

▲

0.03

(4.98%)

Market is closed - opens 8 PM, 27 Dec 2024

View live Novabay Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Novabay Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Novabay Pharmaceuticals. Get details on the Indian mutual funds that are investing in Novabay Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Novabay Pharmaceuticals's financials.

Novabay Pharmaceuticals share price movements

Today's Low: $0.52
Today's High: $0.57
$0.57
9.65%
Downside
Day's Volatility :9.65%
Upside
0.0%
52 Weeks Low: $0.36
52 Weeks High: $9.08
$0.57
36.65%
Downside
52 Weeks Volatility :96.02%
Upside
93.72%

Novabay Pharmaceuticals Returns

Period	Novabay Pharmaceuticals Inc	Index (Russel 2000)
3 Months	-23.96%	0.0%
6 Months	-75.57%	0.0%
1 Year	-92.73%	0.0%
3 Years	-99.89%	-21.1%

Novabay Pharmaceuticals Key Statistics

in dollars & INR

Previous Close	$0.5399
Open	$0.555
Today's High	$0.57
Today's Low	$0.515
Market Capitalization	$2.6M
Today's Volume	$22.9K
52 Week High	$9.079
52 Week Low	$0.3611
Revenue TTM	$13.1M
EBITDA	$-5.0M
Earnings Per Share (EPS)	$-74.61
Profit Margin	-77.48%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-263.83%

How to invest in Novabay Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Novabay Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Novabay Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Novabay Pharmaceuticals or NBY on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Novabay Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Novabay Pharmaceuticals shares which would translate to 1.496 fractional shares of Novabay Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Novabay Pharmaceuticals, in just a few clicks!

Returns in Novabay Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

Novabay Pharmaceuticals investment value today

Current value as on today

₹9,997

Returns

₹90,003

(-90%)

Returns from Novabay Pharmaceuticals Stock

₹92,328 (-92.33%)

Dollar Returns

₹2,325 (+2.33%)

Indian investors sentiment towards Novabay Pharmaceuticals

-13%

Period: Sep 27, 2024 to Dec 26, 2024. Change in 30 Days versus previous period

Search volume for Novabay Pharmaceuticals on INDmoney from India has reduced in the last 30 days as on Dec 27, 2024. -13% less investors are searching Novabay Pharmaceuticals in the last 30 days versus the previous period.

Analyst Recommendation on Novabay Pharmaceuticals

Buy

83%Buy

16%Hold

0%Sell

Based on 6 Wall street analysts offering stock ratings for Novabay Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Novabay Pharmaceuticals

What analysts predicted

Upside of 553.51%

Current:

$0.57

Target:

$3.73

Insights on Novabay Pharmaceuticals

Price Movement
In the last 6 months, NBY stock has moved down by -75.0%
Increasing Revenue
Revenue is up for the last 2 quarters, 2.4M → 2.44M (in $), with an average increase of 1.7% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, -4.10M → -1.21M (in $), with an average increase of 53.8% per quarter
NBY vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 120.0%
NBY vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 125.1%
Price to Sales
ForNBY every $1 of sales, investors are willing to pay $0.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Novabay Pharmaceuticals Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$12.5M	↓ 31.39%
Net Income	$-6.5M	↓ 11.59%
Net Profit Margin	-52.33%	↓ 11.72%

	FY19	Y/Y Change
Revenue	$6.6M	↓ 47.24%
Net Income	$-10.5M	↑ 60.23%
Net Profit Margin	-158.92%	↓ 106.59%

	FY20	Y/Y Change
Revenue	$9.9M	↑ 50.54%
Net Income	$-11.0M	↑ 5.26%
Net Profit Margin	-111.12%	↑ 47.8%

	FY21	Y/Y Change
Revenue	$8.4M	↓ 15.23%
Net Income	$-6.6M	↓ 40.58%
Net Profit Margin	-77.89%	↑ 33.23%

	FY22	Y/Y Change
Revenue	$14.4M	↑ 71.05%
Net Income	$-16.3M	↑ 147.98%
Net Profit Margin	-112.92%	↓ 35.03%

	FY23	Y/Y Change
Revenue	$14.7M	↑ 2.24%
Net Income	$-9.6M	↓ 40.73%
Net Profit Margin	-65.46%	↑ 47.46%

	Q2 FY23	Q/Q Change
Revenue	$4.6M	↑ 47.57%
Net Income	$-4.0M	↑ 131.86%
Net Profit Margin	-87.46%	↓ 31.79%

	Q3 FY23	Q/Q Change
Revenue	$3.3M	↓ 29.39%
Net Income	$-1.8M	↓ 56.42%
Net Profit Margin	-53.98%	↑ 33.48%

	Q4 FY23	Q/Q Change
Revenue	$3.7M	↑ 14.5%
Net Income	$-4.1M	↑ 133.81%
Net Profit Margin	-110.22%	↓ 56.24%

	Q1 FY24	Q/Q Change
Revenue	$2.6M	↓ 29.41%
Net Income	$-3.2M	↓ 21.76%
Net Profit Margin	-122.16%	↓ 11.94%

	Q2 FY24	Q/Q Change
Revenue	$2.4M	↓ 8.78%
Net Income	$-1.6M	↓ 50.68%
Net Profit Margin	-66.04%	↑ 56.12%

	Q3 FY24	Q/Q Change
Revenue	$2.4M	↑ 1.71%
Net Income	$-1.2M	↓ 23.53%
Net Profit Margin	-49.65%	↑ 16.39%

	FY18	Y/Y Change
Profit	$11.0M	↓ 28.75%

	FY19	Y/Y Change
Profit	$4.9M	↓ 55.83%

	FY20	Y/Y Change
Profit	$6.0M	↑ 22.69%

	FY21	Y/Y Change
Profit	$5.6M	↓ 5.35%

	FY22	Y/Y Change
Profit	$7.8M	↑ 37.84%

	FY23	Y/Y Change
Profit	$7.9M	↑ 1.47%

	Q2 FY23	Q/Q Change
Profit	$2.3M	↑ 19.11%

	Q3 FY23	Q/Q Change
Profit	$1.8M	↓ 20.29%

	Q4 FY23	Q/Q Change
Profit	$1.8M	↓ 1.25%

	Q1 FY24	Q/Q Change
Profit	$1.8M	↓ 1.16%

	Q2 FY24	Q/Q Change
Profit	$1.6M	↓ 11.26%

	Q3 FY24	Q/Q Change
Profit	$1.6M	↑ 0.06%

	FY18	Y/Y Change
Operating Cash Flow	$-5.6M	↓ 11.2%
Investing Cash Flow	$-44.0K	↓ 81.97%
Financing Cash Flow	$5.6M	↑ 2684.58%

	FY19	Y/Y Change
Operating Cash Flow	$-7.9M	↑ 42.4%
Investing Cash Flow	$-19.0K	↓ 56.82%
Financing Cash Flow	$11.7M	↑ 109.08%

	FY20	Y/Y Change
Operating Cash Flow	$-4.7M	↓ 40.46%
Investing Cash Flow	$-26.0K	↑ 36.84%
Financing Cash Flow	$9.8M	↓ 16.58%

	FY21	Y/Y Change
Operating Cash Flow	$-9.2M	↑ 94.7%
Investing Cash Flow	$-12.0M	↑ 46226.92%
Financing Cash Flow	$16.8M	↑ 71.98%

	FY22	Y/Y Change
Operating Cash Flow	$-6.7M	↓ 27.61%
Investing Cash Flow	$-112.0K	↓ 99.07%
Financing Cash Flow	$4.6M	↓ 72.4%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-1.8M	↑ 14.4%
Investing Cash Flow	$-15.0K	↑ 15.38%
Financing Cash Flow	$2.5M	-

Novabay Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Novabay Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Novabay Pharmaceuticals Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Novabay Pharmaceuticals Inc	-9.2%	-75.57%	-92.73%	-99.89%	-99.93%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.02%	-18.97%	11.91%	91.19%
Biontech Se	-3.72%	42.02%	7.95%	-52.72%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	0.1%	24.29%	44.19%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-12.92%	-0.27%	83.92%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Novabay Pharmaceuticals Inc	NA	NA	0.0	-3.26	-2.64	-0.39	NA	0.22
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Novabay Pharmaceuticals Inc	Buy	$2.6M	-99.93%	NA	-77.48%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Novabay Pharmaceuticals

novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across

Organization	Novabay Pharmaceuticals
Employees	24
CEO	Mr. Justin M. Hall Esq.
Industry	Health Technology

Management People of Novabay Pharmaceuticals

Name	Title
Mr. Justin M. Hall Esq.	President, CEO, General Counsel, Chief Compliance Officer, Corporate Secretary & Director
Mr. Tommy Law	Controller, Interim CFO & Treasurer

Important FAQs about investing in Novabay Pharmaceuticals from India :

What is Novabay Pharmaceuticals share price today?

Novabay Pharmaceuticals share price today stands at $0.57, Open: $0.56 ; Previous Close: $0.54 ; High: $0.57 ; Low: $0.52 ; 52 Week High: $9.08 ; 52 Week Low: $0.36. The stock opens at $0.56, after a previous close of $0.54. The stock reached a daily high of $0.57 and a low of $0.52, with a 52-week high of $9.08 and a 52-week low of $0.36.

Can Indians buy Novabay Pharmaceuticals shares?

Yes, Indians can invest in the Novabay Pharmaceuticals (NBY) from India.

With INDmoney, you can buy Novabay Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Novabay Pharmaceuticals at zero transaction cost.

How can I buy Novabay Pharmaceuticals shares from India?

It is very easy to buy Novabay Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Novabay Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Novabay Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Novabay Pharmaceuticals stocks?

To start investing in Novabay Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.